Roche To Complete $1.5B Acquisition Of U.S. Biopharma Company Poseida
Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell therapies to treat several types of blood cancer.
Leave A Comment